INTERSUBJECT VARIABILITY IN THE ANTICOAGULANT RESPONSE TO HEPARIN INVITRO

被引：25

作者：

BJORNSSON, TD ^{[1
]}

WOLFRAM, KM ^{[1
]}

机构：

[1] DUKE UNIV, MED CTR, DEPT MED, DURHAM, NC 27710 USA

来源：

关键词：

D O I：

10.1007/BF00542044

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：491 / 497

页数：7

共 24 条

[1] ABILDGAARD U, 1968, SCAND J HAEMATOL, V5, P440
[2] ANDERSEN P, 1977, HAEMOSTASIS, V6, P339
[3] PROSPECTIVE STUDY OF VALUE OF MONITORING HEPARIN TREATMENT WITH ACTIVATED PARTIAL THROMBOPLASTIN TIME
BASU, D
CADE, J
GALLUS, A
HIRSH, J
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1972, 287 (07) : 324 - +
[4] BJORNSSON TD, 1979, J PHARMACOL EXP THER, V210, P237
[5] MEASUREMENT OF ANTITHROMBIN-III, ALPHA-2-MACROGLOBULIN AND ALPHA-1-ANTITRYPSIN IN PATIENTS WITH DEEP VENOUS THROMBOSIS AND PULMONARY-EMBOLISM
DEBOER, AC
VANRIEL, LAM
DENOTTOLANDER, GJH
[J]. THROMBOSIS RESEARCH, 1979, 15 (1-2) : 17 - 25
[6] INHERITED ANTITHROMBIN DEFICIENCY CAUSING THROMBOPHILIA
EGEBERG, O
[J]. THROMBOSIS ET DIATHESIS HAEMORRHAGICA, 1965, 13 (3-4): : 516 - &
[7] HETEROGENEITY OF ANTICOAGULANT RESPONSE TO HEPARIN
ESTES, JW
[J]. JOURNAL OF CLINICAL PATHOLOGY, 1972, 25 (01) : 45 - &
[8] ESTES JW, 1974, THROMB DIATH HAEMO, V33, P329
[9] GALLUS AS, 1973, LANCET, V2, P806
[10] GOLDSTEIN A, 1974, PRINCIPLES DRUG ACTI, P82